Feng Hui, Ren Min, Rubin Charles S
Department of Molecular Pharmacology, Atran Laboratories, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
J Biol Chem. 2006 Jun 30;281(26):17815-26. doi: 10.1074/jbc.M511898200. Epub 2006 Apr 13.
Protein kinase D (PKD) isoforms are effectors in signaling pathways controlled by diacylglycerol. PKDs contain conserved diacylglycerol binding (C1a, C1b), pleckstrin homology (PH), and Ser/Thr kinase domains. However, the properties of conserved domains may vary within the context of distinct PKD polypeptides. Such functional/structural malleability (plasticity) was explored by studying Caenorhabditis elegans D kinase family-1 (DKF-1), a PKD that governs locomotion in vivo. Phorbol ester binding with C1b alone activates classical PKDs by relieving C1-mediated inhibition. In contrast, C1a avidly ligated phorbol 12-myristate 13-acetate (PMA) and anchored DKF-1 at the plasma membrane. C1b bound PMA (moderate affinity) and cooperated with C1a in targeting DKF-1 to membranes. Mutations at a "Pro(11)" position in C1 domains were inactivating; kinase activity was minimal at PMA concentrations that stimulated wild type DKF-1 approximately 10-fold. DKF-1 mutants exhibited unchanged, maximum kinase activity after cells were incubated with high PMA concentrations. Titration in situ revealed that translocation and activation of wild type and mutant DKF-1 were tightly and quantitatively linked at all PMA concentrations. Thus, C1 domains positively regulated phosphotransferase activity by docking DKF-1 with pools of activating lipid. A PH domain inhibits kinase activity in classical PKDs. The DKF-1 PH module neither inhibited catalytic activity nor bound phosphoinositides. Consequently, the PH module is an obligatory, positive regulator of DKF-1 activity that is compromised by mutation of Lys(298) or Trp(396). Phosphorylation of Thr(588) switched on DKF-1 kinase activity. Persistent phosphorylation of Thr(588) (activation loop) promoted ubiquitinylation and proteasome-mediated degradation of DKF-1. Each DKF-1 domain displayed novel properties indicative of functional malleability (plasticity).
蛋白激酶D(PKD)亚型是由二酰基甘油控制的信号通路中的效应器。PKD包含保守的二酰基甘油结合结构域(C1a、C1b)、普列克底物蛋白同源结构域(PH)和丝氨酸/苏氨酸激酶结构域。然而,在不同的PKD多肽中,保守结构域的特性可能会有所不同。通过研究秀丽隐杆线虫D激酶家族-1(DKF-1)来探索这种功能/结构的可塑性,DKF-1是一种在体内控制运动的PKD。佛波酯仅与C1b结合,通过解除C1介导的抑制作用来激活经典的PKD。相比之下,C1a能强烈结合佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)并将DKF-1锚定在质膜上。C1b结合PMA(中等亲和力)并与C1a协同作用将DKF-1靶向到膜上。C1结构域中“Pro(11)”位置的突变会导致失活;在刺激野生型DKF-1约10倍的PMA浓度下,激酶活性最低。在用高浓度PMA孵育细胞后,DKF-1突变体表现出不变的最大激酶活性。原位滴定显示,在所有PMA浓度下,野生型和突变型DKF-1的易位和激活紧密且定量相关。因此,C1结构域通过将DKF-1与激活脂质池对接来正向调节磷酸转移酶活性。在经典的PKD中,一个PH结构域会抑制激酶活性。DKF-1的PH模块既不抑制催化活性也不结合磷酸肌醇。因此,PH模块是DKF-1活性的一个必需的正向调节因子,赖氨酸(Lys)298或色氨酸(Trp)396的突变会损害该调节作用。苏氨酸(Thr)588的磷酸化开启了DKF-1的激酶活性。苏氨酸(Thr)588(激活环)的持续磷酸化促进了DKF-1的泛素化和蛋白酶体介导的降解。每个DKF-1结构域都表现出表明功能可塑性的新特性。